Medifast/$MED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Medifast
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Ticker
$MED
Sector
Consumer Essentials
Primary listing
NYSE
Employees
504
Headquarters
Website
Medifast Metrics
BasicAdvanced
$132M
38.89
$0.33
0.82
-
Price and volume
Market cap
$132M
Beta
0.82
52-week high
$20.79
52-week low
$11.57
Average daily volume
210K
Financial strength
Current ratio
4.47
Quick ratio
3.522
Long term debt to equity
3.307
Total debt to equity
6.05
Dividend payout ratio (TTM)
5.39%
Profitability
EBITDA (TTM)
26.691
Gross margin (TTM)
73.84%
Net profit margin (TTM)
0.76%
Operating margin (TTM)
2.70%
Effective tax rate (TTM)
41.84%
Revenue per employee (TTM)
$950,000
Management effectiveness
Return on assets (TTM)
2.88%
Return on equity (TTM)
1.73%
Valuation
Price to earnings (TTM)
38.885
Price to revenue (TTM)
0.293
Price to book
0.61
Price to tangible book (TTM)
0.61
Price to free cash flow (TTM)
-58.024
Free cash flow yield (TTM)
-1.72%
Free cash flow per share (TTM)
-0.221
Growth
Revenue change (TTM)
-37.62%
Earnings per share change (TTM)
-87.66%
3-year revenue growth (CAGR)
-33.88%
10-year revenue growth (CAGR)
5.67%
3-year earnings per share growth (CAGR)
-70.96%
10-year earnings per share growth (CAGR)
-10.43%
What the Analysts think about Medifast
Analyst ratings (Buy, Hold, Sell) for Medifast stock.
Medifast Financial Performance
Revenues and expenses
Medifast Earnings Performance
Company profitability
Medifast News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medifast stock?
Medifast (MED) has a market cap of $132M as of August 13, 2025.
What is the P/E ratio for Medifast stock?
The price to earnings (P/E) ratio for Medifast (MED) stock is 38.89 as of August 13, 2025.
Does Medifast stock pay dividends?
No, Medifast (MED) stock does not pay dividends to its shareholders as of August 13, 2025.
When is the next Medifast dividend payment date?
Medifast (MED) stock does not pay dividends to its shareholders.
What is the beta indicator for Medifast?
Medifast (MED) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.